** BMO Capital Markets downgrades rating on chemical company Dow DOW.N to "underperform" from "market perform", lowers PT to $22 from $29
** New PT represents a 20.7% downside to the stock's last close
** Brokerage says weakness across its end-markets is resulting in soft pricing and lower volumes/operating rates, which will likely result in severely challenged Q2 EBITDA and 2H estimates coming solidly lower
** "With no end in sight for these anemic earnings levels, there appears a heightened risk DOW may cut the dividend," - BMO adds
** 3 of 22 brokerages rate the stock "buy" or higher, 16 "hold" and 3 "sell" or lower; median PT is $32 - data compiled by LSEG
** Up till last close, stock down 30.8% YTD
(Reporting by Pooja Menon in Bengaluru)
((Pooja.Menon@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.